Author:
Berryman K.A.,Edmunds J.J.,Bunker A.M.,Haleen S.,Bryant J.,Welch K.M.,Doherty A.M.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference35 articles.
1. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K.; Masaki, T. Nature 1988, 332, 411.
2. Inoue, A.; Yanagisawa, M.; Kimura, S.; Kasuya, Y.; Miyauchi, T.; Goto, K.; Masaki, T. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 2863.
3. Doherty, A. M. J. Med. Chem. 1992, 35, 1493.
4. Watanabe, T.; Suzuki, N.; Shimamoto, N.; Fujino, M.; Imada, A. Nature 1990, 344, 114.
5. Saito, Y.; Nakao, K.; Mukoyama, M.; Imura, H. New Engl. J. Med. 1989, 322, 205.
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Design, Synthesis and Pharmacological Evaluation of 2-(3-BenzoyI-4-Hydroxy-1,1-Dioxido-2H-Benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) Acetamide as Antidiabetic Agent;Drug Design, Development and Therapy;2022-11
2. Synthesis and α-Glucosidase Inhibition Activity of 2-[3-(Benzoyl/4-bromobenzoyl)-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yl]-N-arylacetamides: An In Silico and Biochemical Approach;Molecules;2021-05-20
3. Synthesis, X-ray crystal and monoamine oxidase inhibitory activity of 4,6-dihydrobenzo[c]pyrano[2,3-e][1,2]thiazine 5,5-dioxides: In vitro studies and docking analysis;European Journal of Pharmaceutical Sciences;2019-04
4. Synthesis, monoamine oxidase inhibition activity and molecular docking studies of novel 4-hydroxy-N′-[benzylidene or 1-phenylethylidene]-2-H/methyl/benzyl-1,2-benzothiazine-3-carbohydrazide 1,1-dioxides;European Journal of Medicinal Chemistry;2018-01
5. Synthesis of novel pyrazolobenzothiazine 5,5-dioxide derivatives as potent anti-HIV-1 agents;Medicinal Chemistry Research;2013-09-01